[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349935-105":59,"doc-detail-349935-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","oncogenic-role-of-the-slc7a13-slc3a1-cystine-transporter-in-human-luminal-breast-cancer-and-its-cryo-em-structure","Oncogenic role of the SLC7A13-SLC3A1 cystine transporter in human luminal breast cancer and its cryo-EM structure","","Breast cancer is a prevalent malignancy worldwide. Most breast cancers are estrogen receptor (ER)-positive luminal tumors, yet a subset becomes hormone-refractory and incurable. This work links tumor resistance to cystine uptake that supports glutathione (GSH) biosynthesis, suppresses lipid reactive oxygen species (ROS), and prevents ROS-driven ferroptosis. The study shows SLC7A13 amplification/overexpression in luminal breast cancer, impacts survival, and modulates cystine uptake and GSH production, with a cryo-EM structure defining the SLC7A13-SLC3A1 complex and a substrate-binding pocket.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/oncogenic-role-of-the-slc7a13-slc3a1-cystine-transporter-in-human-luminal-breast-cancer-and-its-cryo-em-structure/349935/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/oncogenic-role-of-the-slc7a13-slc3a1-cystine-transporter-in-human-luminal-breast-cancer-and-its-cryo-em-structure/349935.png","ImageObject",300,407,{"name":92,"@type":93},"River Wang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-15","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the proposed role of SLC7A13-SLC3A1 in luminal breast cancer?","Question",{"text":112,"@type":113},"SLC7A13-SLC3A1 cystine transport supports cystine uptake for GSH biosynthesis, helping cells manage ROS and avoid ferroptosis, contributing to oncogenic behavior and therapeutic resistance.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does altering SLC7A13 affect cellular survival and lipid ROS?",{"text":117,"@type":113},"SLC7A13 overexpression promotes cell survival/proliferation, while silencing reduces cystine uptake and GSH biosynthesis, increasing lipid ROS levels.",{"name":119,"@type":110,"acceptedAnswer":120},"What structural information does the cryo-EM study provide?",{"text":121,"@type":113},"The cryo-EM structure of the human SLC7A13-SLC3A1 complex was determined at 2.64 Å, showing a dimer-of-heterodimers architecture and identifying a substrate-binding pocket that suggests a regulatory role.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},349935,1790178360,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","Protein Cell, 2026, 17, 145–156 [https://doi.org/10.1093/procel/pwaf076](https://doi.org/10.1093/procel/pwaf076)  \nAdvance access publication 6 September 2025  \n& Research Article  \nProtein Cell  \nResearch Article  \nOncogenic role of the SLC7A13-SLC3A1 cystine transporter in human luminal breast cancer and its cryo-EM structure  \nJing Dong1,‡, Tianhao Shi2,‡, Bingbiao Lin1,3, Xuetong Liu1, Waner Wei1, Zichi Geng1, Mingcheng Liu1, Renhong Yan2,*,, Jin-Tang Dong1,*,  \n1Department of Human Cell Biology and Genetics, SUSTech Homeostatic Medicine Institute, School of Medicine, Southern University of Science and Technology, Shenzhen 518055, China  \n2Department of Biochemistry, SUSTech Homeostatic Medicine Institute, School of Medicine, Key University Laboratory of Metabolism and Health of Guangdong, Institute for Biological Electron Microscopy, Southern University of Science and Technology, Shenzhen 518055, China  \n3Department of Radiotherapy, Cancer Hospital of Shantou University Medical College, Shantou 518055, China ‡These authors contributed equally to this work.  \n* [Correspondence:](Correspondence: yanrh@sustech.edu.cn)[ yanrh@sustech.edu.cn](Correspondence: yanrh@sustech.edu.cn) (R. Yan), [dongjt@sustech.edu.cn](dongjt@sustech.edu.cn) (J. -T. Dong)  \nAbstract  \nBreast cancer is a prevalent malignancy worldwide. The majority of breast cancers belong to the estrogen receptor (ER)-positive luminal subtype that can be effectively treated with antiestrogen therapies. However, a significant portion of such malignancies become hormone-refractory and incurable. Cancer cells often uptake more cystines to increase glutathione (GSH) biosynthesis and reduce reactive oxygen species (ROS), thereby preventing ROS-induced ferroptosis and leading to therapeutic resistance. However, few molecules of these processes are targetable for cancer therapy. However, few therapeutic targets have been established that target these processes. Here, we report that the gene for SLC7A13, a member of the SLC7A13-SLC3A1 cystine transporter, was amplified and overexpressed in 19.7% and 49.7% of breast cancers, respectively. SLC7A13 amplification and overexpression were associated with worse overall survival and disease-free survival in patients with luminal breast cancer. Functionally, SLC7A13 overexpression promoted, while its silencing attenuated, cell survival or proliferation. Molecularly, SLC7A13 silencing reduced cystine uptake and GSH biosynthesis, leading to increased lipid ROS levels. The cryo-EM structure of the human SLC7A13-SLC3A1 complex was determined at 2.64 Å, revealing a dimer-of-heterodimers architecture similar to that of other SLC3A1-linked transporters. A specific substrate-binding pocket was identified, containing distinct residues, which suggests a regulatory role in the cystine transporter. These findings suggest that the SLC7A13-SLC3A1 cystine transporter is a therapeutic target for treating luminal breast cancer. They also provide the structural insights for therapeutic development targeting the cystine transporter.  \nKeywords cryo-EM, breast cancer, SLC7A13, cystine transporter, ferroptosis  \nIntroduction  \nFerroptosis is a form of cell death induced by the accumulation of lipid peroxides in cell membranes (Dixon et al. , 2012 ; Jiang et al. , 2021) . Cancer cells often develop various mechanisms to overcome ferroptosis; therefore, inducing ferroptosisis considered a therapeutic approach in cancer treatment (Dixon et al. , 2012 ; Tan et al. , 2001) .  \nIn mammalian cells, glutathione (GSH) is the most prevalent antioxidant, and glutathione peroxidase 4 (GPX4) is the primary enzyme that catalyzes the reduction of membrane phospholipid hydroperoxides, as GPX4 transforms GSH into oxidized glutathione, thereby detoxifying lipid peroxides into lipid alcohols (Maiorino et al. , 2018) . GSH is a tripeptide composed of cysteine, glutamate, and glycine.  \nReceived 13 October 2024; accepted 23 June 2025.  \n© The Author(s) 2025. Published by Ox","cbCaij1gxiqNXYCn","https://ap.wps.com/l/cbCaij1gxiqNXYCn","pdf",1304471,12,"English","# Abstract\n# Introduction\n## Ferroptosis and antioxidant defense (GSH/GPX4)\n## Cysteine availability, cystine uptake, and therapeutic rationale\n## Heterodimeric cystine transporters (SLC7/SLC3)","[{\"question\":\"What is the proposed role of SLC7A13-SLC3A1 in luminal breast cancer?\",\"answer\":\"SLC7A13-SLC3A1 cystine transport supports cystine uptake for GSH biosynthesis, helping cells manage ROS and avoid ferroptosis, contributing to oncogenic behavior and therapeutic resistance.\"},{\"question\":\"How does altering SLC7A13 affect cellular survival and lipid ROS?\",\"answer\":\"SLC7A13 overexpression promotes cell survival/proliferation, while silencing reduces cystine uptake and GSH biosynthesis, increasing lipid ROS levels.\"},{\"question\":\"What structural information does the cryo-EM study provide?\",\"answer\":\"The cryo-EM structure of the human SLC7A13-SLC3A1 complex was determined at 2.64 Å, showing a dimer-of-heterodimers architecture and identifying a substrate-binding pocket that suggests a regulatory role.\"}]","Oncogenic role of the SLC7A13-SLC3A1 cystine transporter in human luminal breast cancer and its cryo-EM structure | PDF",1790086327,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e9c66c538e468109fae2939ed6ba8270.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7d2f93f66627496e894fea7fe06a2f44.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e9854f83a3c6923ed2859d071e5ee95a.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cc3eeb4d1fbd3d548fb2d22ccfdf0119.webp",980,1287]